查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945362

2026年全球体外癌症诊断市场报告

In Vitro Cancer Diagnostics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，体外癌症诊断市场发展迅猛，预计将从2025年的114.9亿美元成长到2026年的123.6亿美元，复合年增长率达7.6%。过去几年的成长可归因于癌症发病率上升、分子诊断方法的广泛应用、免疫检测试剂盒的开发、诊断检查室的扩张以及试剂技术的进步等因素。

预计未来几年体外癌症诊断市场将维持强劲成长，2030年市场规模将达到167.8亿美元，复合年增长率（CAGR）为7.9%。预测期内的成长要素包括基于人工智慧的预测分析、个人化癌症治疗的扩展、高通量定序平台的开发、照护现场诊断的成长以及云端诊断软体的普及。预测期内的关键趋势包括基于生物标记的检测、基因谱分析工具、多重检测方法的开发、与实验室资讯管理系统（LIMS）的整合以及快速诊断试剂盒。

预计未来几年，液态生物检体技术的日益普及将推动体外癌症诊断市场的成长。液态生物检体技术是一种微创诊断方法，它能够检测和分析存在于血液、尿液和唾液等体液中的生物标记物，例如循环肿瘤DNA、循环性肿瘤细胞和外泌体，从而监测癌症的存在、进展和治疗反应，尤其适用于癌症的诊断。从血液和其他体液中分离和分析循环肿瘤DNA和循环性肿瘤细胞技术的进步，促成了液态生物检体技术的广泛应用。液态生物检体技术的快速普及，推动了对体外癌症诊断解决方案的需求，而这种需求的驱动力在于非侵入性、即时分子分析工具在癌症检测和治疗指导方面的应用。例如，据英国国家医疗服务体系（NHS England）称，到2025年5月，英国新推出的液态生物检体血液检测预计每年将使多达15,000名疑似肺癌患者和5,000名进行性乳癌女性患者受益。预计检测对象数量将从2025年初推出时的约2,200人增加到2028年的每年约20,000人。因此，液态生物检体技术的日益普及正在推动体外癌症诊断市场的成长。

体外癌症诊断市场的主要企业正致力于开发人工智慧驱动的癌症诊断技术，旨在改善患者预后并促进个人化医疗。人工智慧驱动的癌症诊断利用人工智慧分析从患者检体、影像和基因检测中获得的医学和分子数据，从而实现高度精准的癌症检测、诊断和预测。例如，总部位于瑞士的製药公司罗氏于2024年9月推出了数位病理开放环境（Digital Pathology Open Environment），这是一个协作平台，可安全地整合罗氏和多家第三方开发人员的先进人工智慧影像分析工具。该平台使病理学家能够存取罗氏Navifify数位病理企业软体中的创新演算法，从而提高诊断准确性和工作流程效率。透过促进协作和数据共用，该平台加速了癌症诊断和监测领域的创新，支持精准医疗，实现了更有效的标靶治疗，并扩大了全球先进数位病理解决方案的获取途径。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球体外癌症诊断市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 身临其境型技术（AR/VR/XR）与数位体验
  • 主要趋势
    • 基于生物标记的检测
    • 基因谱分析工具
    • 多重检测方法的开发
    • 与实验室资讯管理系统（LIMS）集成
    • 快速诊断试剂盒

第五章 终端用户产业市场分析

  • 医院
  • 诊断检查室
  • 研究所
  • 居家医疗环境
  • 肿瘤中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球体外癌症诊断市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球体外癌症诊断市场规模、比较及成长率分析
  • 全球体外癌症诊断市场表现：规模与成长，2020-2025年
  • 全球体外癌症诊断市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 依产品类型
  • 试剂盒、仪器、试剂、软体及耗材
  • 透过技术
  • 聚合酵素链锁反应（PCR）、次世代定序（NGS）、萤光原位杂合反应（FISH）、免疫组织化学及其他技术
  • 透过使用
  • 乳癌、肺癌、结肠癌、摄护腺癌及其他应用领域
  • 最终用户
  • 医院、诊断检查室、研究实验室和其他最终用户
  • 按类型细分：套装
  • 免疫检测盒、聚合酵素链锁反应（PCR）试剂盒、酵素免疫分析法（ELISA）试剂盒、流式细胞技术盒
  • 按类型细分：设备
  • 聚合酵素链锁反应（PCR）仪、定序仪、流式细胞仪、影像系统
  • 按类型细分：试剂
  • 酵素、缓衝液、探针和染色剂
  • 按类型细分：软体
  • 数据分析软体、影像处理软体、实验室资讯管理系统（LIMS）软体、诊断报告软体
  • 按类型细分：消耗品
  • 微孔盘、微量吸管尖、试管、玻片

第十章 区域与国家分析

  • 全球体外癌症诊断市场：依地区、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球体外癌症诊断市场：依国家、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 体外癌症诊断市场：竞争格局与市场份额，2024 年
  • 体外癌症诊断市场：公司估值矩阵
  • 体外癌症诊断市场：公司概况
    • F. Hoffmann-La Roche Ltd
    • Danaher Corporation
    • Abbott Laboratories
    • Thermo Fisher Scientific
    • Siemens Healthineers AG

第37章：其他领先和创新企业

  • Illumina Inc, Hologic Inc, Qiagen NV, Bio-Rad Laboratories Inc, Agilent Technologies, Becton, Dickinson and Company（BD）, Sysmex Corporation, LabCorp Holding Corp., Guardant Health, Quest Diagnostics, Exact Sciences, Myriad Genetics Inc, Natera Inc., NeoGenomics Laboratories, NanoString Technologies Inc

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年体外癌症诊断市场：提供新机会的国家
  • 2030年体外癌症诊断市场：新兴细分市场机会
  • 2030年体外癌症诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME3MIVCD01_G26Q1

In vitro cancer diagnostics refers to laboratory-based tests conducted on samples such as blood, tissue, or other body fluids to detect, monitor, or evaluate cancer outside the human body. These diagnostics employ techniques like molecular assays, biomarker analysis, and genetic profiling to identify the presence or progression of cancer. They support early detection, accurate diagnosis, and informed treatment planning for patients.

The key product types in in vitro cancer diagnostics include kits, instruments, reagents, software, and consumables. Kits are ready-to-use sets of reagents and materials designed for diagnostic testing, enabling biomarker detection, supporting disease monitoring, and assisting in treatment evaluation. Technologies used include polymerase chain reaction (PCR), next-generation sequencing (NGS), fluorescence in situ hybridization (FISH), immunohistochemistry, and others. These diagnostics are applied across multiple cancer types, including breast cancer, lung cancer, colorectal cancer, and prostate cancer, and serve end users such as hospitals, diagnostic laboratories, research institutes, home care settings, and others.

Tariffs are impacting the in vitro cancer diagnostics market by increasing costs of instruments, kits, reagents, and software components. Kits and instruments are most affected, particularly in North America and Europe due to import dependence. Positive effects include stimulation of local manufacturing, innovation in cost-efficient diagnostic kits, and improved domestic production capabilities.

The in vitro cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides in vitro cancer diagnostics market statistics, including in vitro cancer diagnostics industry global market size, regional shares, competitors with a in vitro cancer diagnostics market share, detailed in vitro cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the in vitro cancer diagnostics industry. This in vitro cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The in vitro cancer diagnostics market size has grown strongly in recent years. It will grow from $11.49 billion in 2025 to $12.36 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rising cancer prevalence, adoption of molecular diagnostics, development of immunoassay kits, expansion of diagnostic laboratories, advancements in reagent technologies.

The in vitro cancer diagnostics market size is expected to see strong growth in the next few years. It will grow to $16.78 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to AI-enabled predictive analytics, expansion in personalized oncology, development of high-throughput sequencing platforms, growth in point-of-care diagnostics, adoption of cloud-based diagnostic software. Major trends in the forecast period include biomarker-based detection, genetic profiling tools, multiplex assay development, integration with laboratory information systems (lims), rapid diagnostic kits.

The rising adoption of liquid biopsy technologies is expected to enhance the growth of the in vitro cancer diagnostics market in the coming years. Liquid biopsy technologies refer to minimally invasive diagnostic methods that detect and analyze biomarkers such as circulating tumor DNA, circulating tumor cells, or exosomes present in body fluids like blood, urine, or saliva to monitor disease presence, progression, or response to treatment, particularly in cancer. The use of liquid biopsy technologies is increasing due to advancements in isolating and analyzing circulating tumor DNA and circulating tumor cells from blood and other body fluids. In vitro cancer diagnostic solutions are experiencing higher demand as the rapid adoption of liquid biopsy technologies encourages companies to implement non invasive and real time molecular profiling tools for cancer detection and treatment guidance. For example, in May 2025, according to NHS England, a UK based public healthcare system, the new liquid biopsy blood test rollout in the UK is expected to benefit up to 15,000 patients with suspected lung cancer and 5,000 women with advanced breast cancer annually, expanding from about 2,200 patients tested during the early 2025 rollout to an estimated 20,000 patients per year by 2028. Therefore, the rising adoption of liquid biopsy technologies is enhancing the growth of the in vitro cancer diagnostics market.

Leading companies operating in the in vitro cancer diagnostics market are emphasizing the development of AI-driven cancer diagnostics to improve patient outcomes and advance personalized healthcare. AI-driven cancer diagnostics involve the use of artificial intelligence to analyze medical and molecular data from patient samples, imaging, or genetic tests, enabling highly accurate detection, diagnosis, and prediction of cancer. For instance, in September 2024, Roche, a Switzerland-based pharmaceutical company, introduced the Digital Pathology Open Environment, a collaborative platform that securely integrates advanced AI-based image analysis tools from Roche and multiple third-party developers. The platform allows pathologists to access innovative algorithms within Roche's Navify Digital Pathology enterprise software, enhancing diagnostic precision and workflow efficiency. By fostering collaboration and data sharing, the platform accelerates innovation in cancer diagnostics and research, supports precision medicine, and enables more effective targeted treatments, expanding global access to advanced digital pathology solutions.

In February 2024, Veracyte Inc., a US-based molecular diagnostics company, acquired C2i Genomics, Inc. for an undisclosed amount. Through this acquisition, Veracyte aims to expand its presence across the cancer care continuum by incorporating AI-driven whole-genome minimal residual disease testing to enhance treatment monitoring and detect disease recurrence. C2i Genomics Inc. is a US-based biotechnology company that provides in vitro cancer diagnostics.

Major companies operating in the in vitro cancer diagnostics market are F. Hoffmann-La Roche Ltd, Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers AG, Illumina Inc, Hologic Inc, Qiagen N.V, Bio-Rad Laboratories Inc, Agilent Technologies, Becton, Dickinson and Company (BD), Sysmex Corporation, LabCorp Holding Corp., Guardant Health, Quest Diagnostics, Exact Sciences, Myriad Genetics Inc, Natera Inc., NeoGenomics Laboratories, NanoString Technologies Inc, Caris Life Sciences, Transasia Bio-Medicals Ltd, Autobio Diagnostics Co Ltd, QuidelOrtho Corporation, Cancer Diagnostics Inc, Predicine Inc, Strata Oncology, Biocept Inc, Lucence Diagnostics

North America was the largest region in the in vitro cancer diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in vitro cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The in vitro cancer diagnostics market consists of revenues earned by entities by providing services such as molecular diagnostic testing, biopsy and cytology analysis, companion diagnostic services, and next-generation sequencing (NGS) services. The market value includes the value of related goods sold by the service provider or included within the service offering. The in vitro cancer diagnostics market also includes sales of cancer biomarker kits, molecular diagnostic assays, flow cytometry kits, tissue-based diagnostic kits, and genomic testing panels. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In Vitro Cancer Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses in vitro cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in vitro cancer diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in vitro cancer diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Kits; Instruments; Reagents; Software; Consumables
  • 2) By Technology: Polymerase Chain Reaction (PCR); Next-Generation Sequencing (NGS); Fluorescence In Situ Hybridization (FISH); Immunohistochemistry; Other Technologies
  • 3) By Application: Breast Cancer; Lung Cancer; Colorectal Cancer; Prostate Cancer; Other Applications
  • 4) By End User: Hospitals; Diagnostic Laboratories; Research Institutes; Other End Users
  • Subsegments:
  • 1) By Kits: Immunoassay Kits; Polymerase Chain Reaction (PCR) Kits; Enzyme-Linked Immunosorbent Assay (ELISA) Kits; Flow Cytometry Kits
  • 2) By Instruments: Polymerase Chain Reaction (PCR) Instruments; Sequencers; Flow Cytometers; Imaging Systems
  • 3) By Reagents: Enzymes; Buffers; Probes; Stains
  • 4) By Software: Data Analysis Software; Imaging Software; Laboratory Information Management System (LIMS) Software; Diagnostic Reporting Software
  • 5) By Consumables: Microplates; Pipette Tips; Tubes; Slides
  • Companies Mentioned: F. Hoffmann-La Roche Ltd; Danaher Corporation; Abbott Laboratories; Thermo Fisher Scientific; Siemens Healthineers AG; Illumina Inc; Hologic Inc; Qiagen N.V; Bio-Rad Laboratories Inc; Agilent Technologies; Becton; Dickinson and Company (BD); Sysmex Corporation; LabCorp Holding Corp.; Guardant Health; Quest Diagnostics; Exact Sciences; Myriad Genetics Inc; Natera Inc.; NeoGenomics Laboratories; NanoString Technologies Inc; Caris Life Sciences; Transasia Bio-Medicals Ltd; Autobio Diagnostics Co Ltd; QuidelOrtho Corporation; Cancer Diagnostics Inc; Predicine Inc; Strata Oncology; Biocept Inc; Lucence Diagnostics
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. In Vitro Cancer Diagnostics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global In Vitro Cancer Diagnostics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. In Vitro Cancer Diagnostics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global In Vitro Cancer Diagnostics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Immersive Technologies (Ar/Vr/Xr) & Digital Experiences
  • 4.2. Major Trends
    • 4.2.1 Biomarker-Based Detection
    • 4.2.2 Genetic Profiling Tools
    • 4.2.3 Multiplex Assay Development
    • 4.2.4 Integration With Laboratory Information Systems (Lims)
    • 4.2.5 Rapid Diagnostic Kits

5. In Vitro Cancer Diagnostics Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Laboratories
  • 5.3 Research Institutes
  • 5.4 Home Care Settings
  • 5.5 Oncology Centers

6. In Vitro Cancer Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global In Vitro Cancer Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global In Vitro Cancer Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global In Vitro Cancer Diagnostics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global In Vitro Cancer Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global In Vitro Cancer Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global In Vitro Cancer Diagnostics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. In Vitro Cancer Diagnostics Market Segmentation

  • 9.1. Global In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Kits, Instruments, Reagents, Software, Consumables
  • 9.2. Global In Vitro Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Fluorescence In Situ Hybridization (FISH), Immunohistochemistry, Other Technologies
  • 9.3. Global In Vitro Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Other Applications
  • 9.4. Global In Vitro Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Diagnostic Laboratories, Research Institutes, Other End Users
  • 9.5. Global In Vitro Cancer Diagnostics Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Immunoassay Kits, Polymerase Chain Reaction (PCR) Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Flow Cytometry Kits
  • 9.6. Global In Vitro Cancer Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR) Instruments, Sequencers, Flow Cytometers, Imaging Systems
  • 9.7. Global In Vitro Cancer Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Enzymes, Buffers, Probes, Stains
  • 9.8. Global In Vitro Cancer Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Data Analysis Software, Imaging Software, Laboratory Information Management System (LIMS) Software, Diagnostic Reporting Software
  • 9.9. Global In Vitro Cancer Diagnostics Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Microplates, Pipette Tips, Tubes, Slides

10. In Vitro Cancer Diagnostics Market Regional And Country Analysis

  • 10.1. Global In Vitro Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global In Vitro Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific In Vitro Cancer Diagnostics Market

  • 11.1. Asia-Pacific In Vitro Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China In Vitro Cancer Diagnostics Market

  • 12.1. China In Vitro Cancer Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India In Vitro Cancer Diagnostics Market

  • 13.1. India In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan In Vitro Cancer Diagnostics Market

  • 14.1. Japan In Vitro Cancer Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia In Vitro Cancer Diagnostics Market

  • 15.1. Australia In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia In Vitro Cancer Diagnostics Market

  • 16.1. Indonesia In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea In Vitro Cancer Diagnostics Market

  • 17.1. South Korea In Vitro Cancer Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan In Vitro Cancer Diagnostics Market

  • 18.1. Taiwan In Vitro Cancer Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia In Vitro Cancer Diagnostics Market

  • 19.1. South East Asia In Vitro Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe In Vitro Cancer Diagnostics Market

  • 20.1. Western Europe In Vitro Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK In Vitro Cancer Diagnostics Market

  • 21.1. UK In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany In Vitro Cancer Diagnostics Market

  • 22.1. Germany In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France In Vitro Cancer Diagnostics Market

  • 23.1. France In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy In Vitro Cancer Diagnostics Market

  • 24.1. Italy In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain In Vitro Cancer Diagnostics Market

  • 25.1. Spain In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe In Vitro Cancer Diagnostics Market

  • 26.1. Eastern Europe In Vitro Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia In Vitro Cancer Diagnostics Market

  • 27.1. Russia In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America In Vitro Cancer Diagnostics Market

  • 28.1. North America In Vitro Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA In Vitro Cancer Diagnostics Market

  • 29.1. USA In Vitro Cancer Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada In Vitro Cancer Diagnostics Market

  • 30.1. Canada In Vitro Cancer Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America In Vitro Cancer Diagnostics Market

  • 31.1. South America In Vitro Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil In Vitro Cancer Diagnostics Market

  • 32.1. Brazil In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East In Vitro Cancer Diagnostics Market

  • 33.1. Middle East In Vitro Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa In Vitro Cancer Diagnostics Market

  • 34.1. Africa In Vitro Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa In Vitro Cancer Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. In Vitro Cancer Diagnostics Market Regulatory and Investment Landscape

36. In Vitro Cancer Diagnostics Market Competitive Landscape And Company Profiles

  • 36.1. In Vitro Cancer Diagnostics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. In Vitro Cancer Diagnostics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. In Vitro Cancer Diagnostics Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

37. In Vitro Cancer Diagnostics Market Other Major And Innovative Companies

  • Illumina Inc, Hologic Inc, Qiagen N.V, Bio-Rad Laboratories Inc, Agilent Technologies, Becton, Dickinson and Company (BD), Sysmex Corporation, LabCorp Holding Corp., Guardant Health, Quest Diagnostics, Exact Sciences, Myriad Genetics Inc, Natera Inc., NeoGenomics Laboratories, NanoString Technologies Inc

38. Global In Vitro Cancer Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The In Vitro Cancer Diagnostics Market

40. In Vitro Cancer Diagnostics Market High Potential Countries, Segments and Strategies

  • 40.1 In Vitro Cancer Diagnostics Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 In Vitro Cancer Diagnostics Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 In Vitro Cancer Diagnostics Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer